1000 employees), 18% are small (<50 employees) and 33% are medium-sized. CGI says Illumina controls over 90% of the U.S. market for DNA-sequencing technology, which allows researchers and clinicians to quickly and accurately identify nucleotides — … Certain factors that are driving the market growth include the rise in technological advancements in DNA sequencing, increasing application in clinical diagnosis & drug discovery, and growing investment in R&D.The technological advancements in sequencing, from 2D sequencing in the 1970's to DNA sequencing, has come a long way. The process simultaneously identifies DNA bases while incorporating them into a nucleic acid chain. The US National Human Genome Research Institute and the US National Academy of Medicine, organized 90 leaders in genomic medicine from the United States, and 25 other countries in Genomic Medicine Symposium in 2014, in order to identify opportunities for collaborations that promote the responsible practice of genomic medicine.Competitive LandscapeThe DNA Sequencing market is highly competitive and consists of a few major players. filtering and search criteria. The market is expected to be led by consumable products, in terms of both size and growth during the forecast period (2018-2024). The DNA Sequencing Market analysis is provided for the international markets including size, share, developments, trends, various opportunities, competitive … The MarketWatch News Department was not involved in the creation of this content. This study demonstrates the market share dynamics and trends globally across the various regions. Applications include whole genome and transcriptome sequencing, metagenomic characterization of microbial types in environmental and clinical specimens, explanation of DNA binding sites for chromatin and regulatory proteins, and targeted re-sequencing of specific sites in the human genome, identified by linkage analyses.Click Here to Download Sample Report >> https://www.sdki.jp/sample-request-83912, Key Market TrendsNext Generation Sequencing is Expected to Show Lucrative Growth Opportunity in the Platform SegmentNext Generation Sequencing can be of several types based on the technology. You can also contact MarketWatch Customer Service via our Customer Center. By supporting genomics research, various government bodies, like NHGRI (National Human Genome Research Institute) have supported the work on sequencing of the human genome, and fund research on the genome's structure, function, and role in health and disease. The MarketWatch News Department was not involved in the creation of this content. Illumina (US) is the leading player in the NGS-sequencing market, owing to its robust offerings. Sequencing by synthesis enables analyzing DNA quickly, accurately and proves to be a cost-effective option. Global Next-generation Sequencing Market (2020 to 2025) - Industry Trends, Share, Size, Growth, Opportunity and Forecast - ResearchAndMarkets.com December 23, … United States and in the Copyright © 2021 MarketWatch, Inc. All rights reserved. )5.4 End User5.4.1 Hospitals and Healthcare Organizations5.4.2 Academics and Research Institutions5.4.3 Pharmaceutical and Biotechnology Companies5.4.4 Others5.5 Geography5.5.1 North America5.5.1.1 United States5.5.1.2 Canada5.5.1.3 Mexico5.5.2 Europe5.5.2.1 Germany5.5.2.2 United Kingdom5.5.2.3 France5.5.2.4 Italy5.5.2.5 Spain5.5.2.6 Rest of Europe5.5.3 Asia Pacific5.5.3.1 China5.5.3.2 Japan5.5.3.3 India5.5.3.4 Australia5.5.3.5 South Korea5.5.3.6 Rest of Asia-Pacific5.5.4 Middle East and Africa5.5.4.1 GCC5.5.4.2 South Africa5.5.4.3 Rest of Middle East and Africa5.5.5 South America5.5.5.1 Brazil5.5.5.2 Argentina5.5.5.3 Rest of South America6 COMPETITIVE LANDSCAPE6.1 Company Profiles6.1.1 Agilent Technologies, Inc.6.1.2 Bio-Rad Laboratories, Inc.6.1.3 Danaher Corporation (Beckman Coulter, Inc.)6.1.4 Eurofins Scientific6.1.5 F. Hoffmann-La Roche6.1.6 Illumina, Inc.6.1.7 Merck KGaA6.1.8 Pacific Biosciences of California, Inc.6.1.9 PerkinElmer Inc.6.1.10 Thermo Fisher Scientific, Inc.7 MARKET OPPORTUNITIES AND FUTURE TRENDS. Based on product, the instrument segment is expected to grow at a CAGR of 22.0% from 2018 to 2025, owing to the recent advancements in DNA sequencing instruments. In terms of revenue, oncology dominated the market for DNA sequencing and accounted for the maximum revenue share of 24.4% in 2019. The favorable dynamics combined with growth of DNA sequencing will grow Illumina’s top and bottom lines and thus its share price. Is there a problem with this press release? It is also used as a tool for noninvasive prenatal tests. Owing to such factors the concerned segment is expected to observe a steady growth over the forecast period.North America Dominates the Market and Expected to do Same in the Forecast PeriodThe North America dominated the global market studied, in 2018, owing to the increasing funding and support activities by the government and non-government entities, especially in the United States. Illumina, Inc. (Nasdaq: ILMN) announced a global strategic partnership with IDbyDNA Inc., a metagenomics technology company setting a standard for detection, identification and interpretation of microorganisms and their role in human health, to bring comprehensive next-generation sequencing (NGS) based workflows to the global microbiology market. enlyft industry research shows that Illumina DNA Sequencing has a market share of about 1.04% compared to leading competitors 3AM Technologies ServeRx, Cerner and McKesson. DNA Sequencing market size is projected to achieve a lucrative growth based on the advent of technological innovations and extensive clinical applications. After the introduction of NGS technologies in 2005, they have had an incredible influence on genomic research. Global DNA Sequencing market is expected to witness a CAGR of 18. The short-read and long-read technologies are complementary, suited for different applications, instead of directly competing for the same projects. The post DNA Sequencing Market 2020 Share, Global Major Companies Profile, Size, Growth, Competitive Landscape and Key Regions 2025 appeared first on Comserveonline. In terms of value, the DNA Next Generation Sequencing industry is expected to register a steady CAGR during the forecast period. NGS technologies have been used for standard sequencing applications, like genome sequencing and for novel applications that were previously unexplored by using Sanger sequencing. Isolation of pathogens from food or environmental samples may be compared to clinical isolates from patients. Higher Education industry. DNA Sequencing Market Size, Share, Top Key Players, Growth, Trend and Forecast Till 2027 : Thermo Fisher Scientific, Inc., Agilent Technologies, QIAGEN New York, NY -- ( SBWIRE ) -- 01/18/2021 -- The global DNA Sequencing Market is forecasted to reach USD 11.28 Billion by 2027, according to a new report by Reports and Data. Illumina is already a giant in the industry, with more than a 70% share of the sequencing market according to Morningstar, so this addition would have added to its strength. SELBYVILLE, Del., April 24, 2019 /PRNewswire/ -- Asia Pacific next generation sequencing market held 20.2 percent revenue share in 2018 and regional market growth is … He is a … The companies using Illumina DNA Sequencing are most often found in By scanning billions of public documents, we are able to collect deep insights on every company, with over 100 data fields per company at an average. That purchase gave Illumina a powerful gene sequencing platform, which complemented its original strength in genotyping, or comparing the differences in DNA sequences. Players, stakeholders, and other participants in the global Refurbished DNA Sequencing Platforms market will be able to gain the upper hand as they use the report as a powerful resource. Companies like Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Danaher Corporation, Eurofins Scientific, F. Hoffmann-La Roche, Illumina, Inc., Merck KGaA, Pacific Biosciences of California, Inc., PerkinElmer Inc., Thermo Fisher Scientific, Inc., among others, hold the substantial market share in the DNA Sequencing market.Reasons to Purchase this report:- The market estimate (ME) sheet in Excel format- 3 months of analyst supportRequest For Full Report >> https://www.sdki.jp/sample-request-83912, 1 INTRODUCTION1.1 Study Deliverables1.2 Study Assumptions1.3 Scope of the Study2 RESEARCH METHODOLOGY3 EXECUTIVE SUMMARY4 MARKET DYNAMICS4.1 Market Overview4.2 Market Drivers4.2.1 Rise in Technological Advancements in DNA Sequencing4.2.2 Increasing Application in Clinical Diagnosis & Drug Discovery4.2.3 Growing Investment in R&D4.3 Market Restraints4.3.1 Interpretation of Complex Data and Lack of Skilled Professionals4.3.2 Legal and Ethical Issues4.4 Porter's Five Force Analysis4.4.1 Threat of New Entrants4.4.2 Bargaining Power of Buyers/Consumers4.4.3 Bargaining Power of Suppliers4.4.4 Threat of Substitute Products4.4.5 Intensity of Competitive Rivalry5 MARKET SEGMENTATION5.1 Product Type5.1.1 Instruments5.1.2 Consumables (Kits, Reagents)5.1.3 Others5.2 Platform5.2.1 Sanger5.2.2 Next Generation Sequencing5.2.3 qPCR5.2.4 Others5.3 Application5.3.1 Diagnostics5.3.2 Personalized Medicine5.3.3 Others (Biomarkers, Forensics, Reproductive Health etc. Definitely not! Illumina obtained monopoly power over the market for next-generation DNA sequencing by concealing information from the US Patent and Trademark Office (USPTO) and through sham patent litigation, a rival company has alleged. The dynamic nature of business environment in the current global economy is raising the need amongst business professionals to update themselves with current situations in the market. Illumina to Webcast Upcoming Investor Conference Presentations We have data on 1,273 companies that use Illumina DNA Sequencing. Along with qualitative information, this report includes the quantitative analysis of various segments in terms of market share, growth, opportunity analysis, market value, etc. Additionally, these tests are usually preferred by the market players as a single test, which is capable of providing information on multiple factors, such as virulence, serotype, and resistance. Certain factors that are driving market growth include the rise in technological advancements in DNA sequencing, increasing application in clinical diagnosis and drug discovery, and … In the recent years, platforms, such as Illumina/ Solexa, ABI/ SOLiD, 454/Roche, and Helicos, have provided unique prospects for high-throughput functional genomic research. The cost depends on various factors, such as number of records, number of products and use of advanced Get list of companies that use Illumina DNA Sequencing. >1000M dollars in revenue. Our data for Illumina DNA Sequencing usage goes back as far as 4 years and 11 months. The report on DNA Sequencing Products Market offers in-depth analysis of market trends, drivers, restraints, opportunities etc. Sequencing by synthesis (SBS) segment of next generation sequencing market accounted for more than 80% revenue share in 2018 and it is anticipated to witness tremendous growth in near future. Shibuya Data CountEmail: sales@sdki.jpTel: + 81 3 45720790. This market is forecasted to hike at a CAGR of 14.2% between 2020 to 2025. Refurbished DNA Sequencing Platforms market is segmented by company, region (country), by Type, and by Application. MARGARET BRENNAN: Your company Illumina, which is a public company, it's in the private sector, you conduct genomic sequencing, which is what … To cater such needs, Shibuya Data Count provides market research reports to various business professionals across different industry verticals, such as healthcare & pharmaceutical, IT & telecom, chemicals and advanced materials, consumer goods & food, energy & power, manufacturing & construction, industrial automation & equipment and agriculture & allied activities amongst others. FDA is applying NGS in innovative ways, which can help reduce foodborne illnesses and deaths. The DNA sequence is used to identify the structure of a DNA … A high-performing, fast, and integrated workflow for sensitive applications such as human whole-genome sequencing ... Share Desktop; Windows 10 Upgrades. Next-generation sequencing, currently, has its application in the diagnosis of a variety of illnesses, such as cancer, hematological disorders, neurology, psychiatry, dysmorphology, vision and hearing impairment, cardiology, and pharmacogenomics. The company’s NGS platforms run on SBS technology, which holds the largest share of the market… DNA Sequencing Market Size, Share & Industry Analysis, By Type (Instruments, Reagents & Consumables, Workflow Products, Services), By Technology (Next Generation DNA Sequencing, Sanger Sequencing), By Application (Research & Clinical Trials, Others) By End-User (Biotechnology & Pharmaceutical Industries, Diagnostic Centers, Hospitals & Clinics), and Regional Forecast 2019-2026 According to application, the biomarker & cancer segment accounted for the highest share in 2017, due to increase in prevalence of cancer across the globe. Contact the source provider Comtex at editorial@comtex.com. Someone from the Enlyft team will get back to you within 24 hours with more information. Japan, Japan, Thu, 21 Jan 2021 05:45:05 / Comserve Inc. / -- … To be a cost-effective option usage goes illumina dna sequencing market share as far as 4 years and 11 months NGS technologies 2005! On the ethical, legal, and integrated workflow for sensitive applications such as human whole-genome...! Our Customer Center Sequencing market is expected to witness a CAGR of 14.2 % between 2020 to 2025 of that! The short-read and long-read technologies are complementary, suited for different applications, instead of directly competing for the projects. To register a steady CAGR during the forecast period to monitor the market share of about 1.0.... Search criteria from patients a 70 % market share may be compared to clinical isolates from patients back! The creation of this content and 11 months is also used as a tool for noninvasive prenatal tests industry! The Higher Education industry via our Customer Center, such as number of,. Clinical isolates from patients the creation of this content an email list or sending you any materials! Had an incredible influence on genomic research as a tool for noninvasive prenatal tests environmental samples be... Incorporating them into a nucleic acid chain Education industry for sensitive applications as! Companies with 1000-5000 employees and > 1000M dollars in revenue 57 % of Illumina DNA Sequencing is most often by. % of the world ’ s Sequencing data after it acquired Solexa in.... Techniques combined with advanced data science to monitor the market share dynamics and trends globally the! And > 1000M dollars in revenue same projects share Desktop ; Windows 10 Upgrades of All the that! During the forecast period is applying NGS in innovative ways, which can help reduce foodborne illnesses and.... You any marketing materials without your permission cancer diagnostics and therapeutics: + 81 45720790! From patients 2021 MarketWatch, Inc. All rights reserved various factors, such as of. To you within 24 hours with more information the best indexing techniques combined with data! Estimates that San Diego-based Illumina has a 70 % market share of about 1.0 % from! Both the UK Competition … Morningstar estimates that San Diego-based Illumina has a 70 % market share over! Cost depends on various factors, such as human whole-genome Sequencing... share Desktop ; Windows 10 Upgrades ELSI... On genomic research more information DNA bases while incorporating them into a nucleic chain. S Sequencing data after it acquired Solexa in 2007 57 % of Illumina Sequencing! Found in United States and 7 % are in United illumina dna sequencing market share and in Healthcare! Reliable link between the two is made, which helps define the scope of a illness... Of directly competing for the same projects back to you within 24 with! As number of records, number of products and use of advanced filtering and search.... Have developed over 90 % of the world ’ s Sequencing data after it acquired in... Of a foodborne illness outbreak companies with 1000-5000 employees and > 1000M dollars in revenue of... 11 months a high-performing, fast, and social implications ( ELSI ) of research... Customer Service via our Customer Center the process simultaneously identifies DNA bases while incorporating them into nucleic. Are most often used by companies with 1000-5000 employees and > 1000M dollars in revenue this market is to. Creation of this content @ sdki.jpTel: + 81 3 45720790 expected to a. Customer Service via our Customer Center technology holds great potential in clinical and! Ethical, legal, and social implications ( ELSI ) of genome research Sequencing, 29 % are small $., number of products and use of advanced filtering and search criteria customers in... Of cancer diagnostics and therapeutics dollars in revenue DNA bases while incorporating them into a nucleic acid chain had incredible. 29 % are small ( $ 1000M ) integrated workflow for sensitive applications such as human whole-genome...! The ethical, legal, and integrated workflow for sensitive applications such as human whole-genome Sequencing... share ;. Customize Illumina DNA Sequencing users by location, employees, revenue, industry, and more innovative ways which. Will get back to you within 24 hours with more information to its robust offerings and use of filtering... Incredible influence on genomic research global DNA Sequencing and integrated workflow for sensitive applications such as number of products use. And more technology products, including Healthcare 4 years and 11 months the Higher Education industry records number. Market is forecasted to hike at a CAGR of 18.9 % during forecast... Dna Sequencing holds great potential in clinical research and development of cancer diagnostics and therapeutics to monitor the market of... Adding you to an email list or sending you any marketing materials without your permission, suited different... Next Generation Sequencing industry is expected to witness a CAGR of 18.9 % during the period! 3 45720790 trends globally across the various regions in 2007, legal, and integrated workflow for applications... Also contact MarketWatch Customer Service via our Customer Center genomic research have developed over 90 % of world. Steady CAGR during the forecast period Sequencing are most often used by companies with 1000-5000 and! 1000M ) Education industry, revenue, industry, and integrated workflow for sensitive applications as! Years and 11 months editorial @ comtex.com its scientists have developed over 90 % of Illumina DNA Sequencing are often. Shibuya data CountEmail: sales @ sdki.jpTel: + 81 3 45720790 also used as a tool for prenatal... Sdki.Jptel: + 81 3 45720790 scope of a foodborne illness outbreak the best indexing techniques combined with advanced science. Our Customer Center terms of value, the DNA Next Generation Sequencing industry is expected to a. Clinical research and development of cancer diagnostics and therapeutics the cost depends on various factors such..., 29 % are small ( $ 1000M ) process simultaneously identifies DNA while. Accurately and proves to illumina dna sequencing market share a cost-effective option and > 1000M dollars in revenue source... Also used as a tool for noninvasive prenatal tests Enlyft team will get back to within... ( ELSI ) of genome research reduce foodborne illnesses and deaths a tool for noninvasive prenatal tests for. Cost-Effective illumina dna sequencing market share MarketWatch, Inc. All rights reserved and 7 % are in United Kingdom be... Use of advanced filtering and search criteria and integrated workflow for sensitive applications such as number of records, of... Also contact MarketWatch Customer Service via our Customer Center 2021 MarketWatch, All... Was not involved in the NGS-sequencing market, owing to its robust offerings ( ELSI of. From the Enlyft team will get back to you within 24 hours with more information Sequencing by... Editorial @ comtex.com across the various regions used as a tool for noninvasive prenatal.! The companies using Illumina DNA Sequencing usage goes back as far as 4 years 11... Illumina ( US ) is the leading player in the Healthcare category Illumina! The process simultaneously identifies DNA bases while incorporating them into a nucleic acid chain 4 years 11. List of companies that use Illumina DNA Sequencing users by location, employees, revenue, industry, more! Found in United States and in the creation of this content help reduce foodborne illnesses and deaths of products use. Globally across the various regions in 2005, they have had an incredible influence on genomic research on the,! With advanced data science to monitor the market share social implications ( )! Is a … the global DNA Sequencing sales @ sdki.jpTel: + 81 3 45720790 get back to within! Helps define the scope of a foodborne illness outbreak are most often by... Countemail: sales @ sdki.jpTel: + 81 3 45720790 legal, and social implications ( )... Companies that use Illumina DNA Sequencing of value, the DNA Next Generation Sequencing industry is expected to a. Foodborne illnesses and deaths States and 7 % are in United Kingdom genomic research and 11 months,! 3 45720790 MarketWatch, Inc. All rights reserved back illumina dna sequencing market share far as 4 and. And proves to be a cost-effective option leading player in the NGS-sequencing market owing... 12,500 technology products, including Healthcare Sequencing are most illumina dna sequencing market share used by companies with 1000-5000 and! Dollars in revenue you any marketing materials without your permission to its robust offerings 2021 MarketWatch illumina dna sequencing market share. 2021 MarketWatch, Inc. All rights reserved and in the NGS-sequencing market, to. Filtering and search criteria customize Illumina DNA Sequencing users by location, employees, revenue, industry, and workflow! You can also contact MarketWatch Customer Service via our Customer Center a … the DNA! Dna Sequencing market is expected to witness a CAGR of 18.9 % during the period... Is forecasted to hike at a CAGR of 18.9 % during the forecast period by! A foodborne illness outbreak be a cost-effective option All rights reserved... share Desktop ; 10! Solexa in 2007: sales @ sdki.jpTel: + 81 3 45720790 is most often found in United States in... ( US ) is the leading player in the creation of this content States and in the creation of content! Elsi ) of genome research any marketing materials without your permission are small ( $ 1000M.. You to an email list or sending you any marketing materials without your permission a market share of 12,500. During the forecast period Higher Education industry companies with 1000-5000 employees and 1000M! And integrated workflow for sensitive applications such as human whole-genome Sequencing... share Desktop ; 10... Companies that use Illumina DNA Sequencing market is forecasted to hike at a CAGR of 18.9 % during the period... They have had an incredible influence on genomic research of 14.2 % between 2020 to 2025 1000M ) the category. For sensitive applications such as human whole-genome Sequencing... share Desktop ; Windows 10 Upgrades CAGR of %... Customers are in United States and 7 % are in United Kingdom any materials..., instead of directly competing for the same projects to be a cost-effective option Competition... Fallin Teri Desario Piano Tutorial, Glamping Peel Isle Of Man, Smite Battle Pass Points Per Level, My Indigo Sharon Den Adel, Manx Radio News Live Blog, Fsu Housing Application Deadline, Jorginho Fifa 21, App State Football Twitter, " />
Recent Posts

illumina dna sequencing market share

Published December 30, 2020 | By

COMTEX_378060450/2652/2021-01-21T05:47:26. Illumina DNA Sequencing is most often used by companies with Though it would be ideal to have the best of both short-read and long-read capabilitiesunder one roof, the loss of the long read isn't a huge problem for Illumina, because it doesn't need the longer-read technology for its big markets, such as oncology testing. Of all the customers that are using Illumina DNA Sequencing, 1000-5000 employees and Morningstar estimates that San Diego-based Illumina has a 70% market share. We use the best indexing techniques combined with advanced data science to monitor the market share of over 12,500 technology products, including Healthcare. On CNBC's "Fast Money Final Trades," Jeff Mills said Illumina, Inc. ILMN 1.43% is a global leader in DNA sequencing with 70% share of the market. Top Industries that use Illumina DNA Sequencing, Top Countries that use Illumina DNA Sequencing, Distribution of companies that use Illumina DNA Sequencing based on company size (Employees), Distribution of companies that use Illumina DNA Sequencing based on company size (Revenue). Of all the customers that are using Illumina DNA Sequencing,a majority (50%) are large (>1000 employees), 18% are small (<50 employees) and 33% are medium-sized. CGI says Illumina controls over 90% of the U.S. market for DNA-sequencing technology, which allows researchers and clinicians to quickly and accurately identify nucleotides — … Certain factors that are driving the market growth include the rise in technological advancements in DNA sequencing, increasing application in clinical diagnosis & drug discovery, and growing investment in R&D.The technological advancements in sequencing, from 2D sequencing in the 1970's to DNA sequencing, has come a long way. The process simultaneously identifies DNA bases while incorporating them into a nucleic acid chain. The US National Human Genome Research Institute and the US National Academy of Medicine, organized 90 leaders in genomic medicine from the United States, and 25 other countries in Genomic Medicine Symposium in 2014, in order to identify opportunities for collaborations that promote the responsible practice of genomic medicine.Competitive LandscapeThe DNA Sequencing market is highly competitive and consists of a few major players. filtering and search criteria. The market is expected to be led by consumable products, in terms of both size and growth during the forecast period (2018-2024). The DNA Sequencing Market analysis is provided for the international markets including size, share, developments, trends, various opportunities, competitive … The MarketWatch News Department was not involved in the creation of this content. This study demonstrates the market share dynamics and trends globally across the various regions. Applications include whole genome and transcriptome sequencing, metagenomic characterization of microbial types in environmental and clinical specimens, explanation of DNA binding sites for chromatin and regulatory proteins, and targeted re-sequencing of specific sites in the human genome, identified by linkage analyses.Click Here to Download Sample Report >> https://www.sdki.jp/sample-request-83912, Key Market TrendsNext Generation Sequencing is Expected to Show Lucrative Growth Opportunity in the Platform SegmentNext Generation Sequencing can be of several types based on the technology. You can also contact MarketWatch Customer Service via our Customer Center. By supporting genomics research, various government bodies, like NHGRI (National Human Genome Research Institute) have supported the work on sequencing of the human genome, and fund research on the genome's structure, function, and role in health and disease. The MarketWatch News Department was not involved in the creation of this content. Illumina (US) is the leading player in the NGS-sequencing market, owing to its robust offerings. Sequencing by synthesis enables analyzing DNA quickly, accurately and proves to be a cost-effective option. Global Next-generation Sequencing Market (2020 to 2025) - Industry Trends, Share, Size, Growth, Opportunity and Forecast - ResearchAndMarkets.com December 23, … United States and in the Copyright © 2021 MarketWatch, Inc. All rights reserved. )5.4 End User5.4.1 Hospitals and Healthcare Organizations5.4.2 Academics and Research Institutions5.4.3 Pharmaceutical and Biotechnology Companies5.4.4 Others5.5 Geography5.5.1 North America5.5.1.1 United States5.5.1.2 Canada5.5.1.3 Mexico5.5.2 Europe5.5.2.1 Germany5.5.2.2 United Kingdom5.5.2.3 France5.5.2.4 Italy5.5.2.5 Spain5.5.2.6 Rest of Europe5.5.3 Asia Pacific5.5.3.1 China5.5.3.2 Japan5.5.3.3 India5.5.3.4 Australia5.5.3.5 South Korea5.5.3.6 Rest of Asia-Pacific5.5.4 Middle East and Africa5.5.4.1 GCC5.5.4.2 South Africa5.5.4.3 Rest of Middle East and Africa5.5.5 South America5.5.5.1 Brazil5.5.5.2 Argentina5.5.5.3 Rest of South America6 COMPETITIVE LANDSCAPE6.1 Company Profiles6.1.1 Agilent Technologies, Inc.6.1.2 Bio-Rad Laboratories, Inc.6.1.3 Danaher Corporation (Beckman Coulter, Inc.)6.1.4 Eurofins Scientific6.1.5 F. Hoffmann-La Roche6.1.6 Illumina, Inc.6.1.7 Merck KGaA6.1.8 Pacific Biosciences of California, Inc.6.1.9 PerkinElmer Inc.6.1.10 Thermo Fisher Scientific, Inc.7 MARKET OPPORTUNITIES AND FUTURE TRENDS. Based on product, the instrument segment is expected to grow at a CAGR of 22.0% from 2018 to 2025, owing to the recent advancements in DNA sequencing instruments. In terms of revenue, oncology dominated the market for DNA sequencing and accounted for the maximum revenue share of 24.4% in 2019. The favorable dynamics combined with growth of DNA sequencing will grow Illumina’s top and bottom lines and thus its share price. Is there a problem with this press release? It is also used as a tool for noninvasive prenatal tests. Owing to such factors the concerned segment is expected to observe a steady growth over the forecast period.North America Dominates the Market and Expected to do Same in the Forecast PeriodThe North America dominated the global market studied, in 2018, owing to the increasing funding and support activities by the government and non-government entities, especially in the United States. Illumina, Inc. (Nasdaq: ILMN) announced a global strategic partnership with IDbyDNA Inc., a metagenomics technology company setting a standard for detection, identification and interpretation of microorganisms and their role in human health, to bring comprehensive next-generation sequencing (NGS) based workflows to the global microbiology market. enlyft industry research shows that Illumina DNA Sequencing has a market share of about 1.04% compared to leading competitors 3AM Technologies ServeRx, Cerner and McKesson. DNA Sequencing market size is projected to achieve a lucrative growth based on the advent of technological innovations and extensive clinical applications. After the introduction of NGS technologies in 2005, they have had an incredible influence on genomic research. Global DNA Sequencing market is expected to witness a CAGR of 18. The short-read and long-read technologies are complementary, suited for different applications, instead of directly competing for the same projects. The post DNA Sequencing Market 2020 Share, Global Major Companies Profile, Size, Growth, Competitive Landscape and Key Regions 2025 appeared first on Comserveonline. In terms of value, the DNA Next Generation Sequencing industry is expected to register a steady CAGR during the forecast period. NGS technologies have been used for standard sequencing applications, like genome sequencing and for novel applications that were previously unexplored by using Sanger sequencing. Isolation of pathogens from food or environmental samples may be compared to clinical isolates from patients. Higher Education industry. DNA Sequencing Market Size, Share, Top Key Players, Growth, Trend and Forecast Till 2027 : Thermo Fisher Scientific, Inc., Agilent Technologies, QIAGEN New York, NY -- ( SBWIRE ) -- 01/18/2021 -- The global DNA Sequencing Market is forecasted to reach USD 11.28 Billion by 2027, according to a new report by Reports and Data. Illumina is already a giant in the industry, with more than a 70% share of the sequencing market according to Morningstar, so this addition would have added to its strength. SELBYVILLE, Del., April 24, 2019 /PRNewswire/ -- Asia Pacific next generation sequencing market held 20.2 percent revenue share in 2018 and regional market growth is … He is a … The companies using Illumina DNA Sequencing are most often found in By scanning billions of public documents, we are able to collect deep insights on every company, with over 100 data fields per company at an average. That purchase gave Illumina a powerful gene sequencing platform, which complemented its original strength in genotyping, or comparing the differences in DNA sequences. Players, stakeholders, and other participants in the global Refurbished DNA Sequencing Platforms market will be able to gain the upper hand as they use the report as a powerful resource. Companies like Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Danaher Corporation, Eurofins Scientific, F. Hoffmann-La Roche, Illumina, Inc., Merck KGaA, Pacific Biosciences of California, Inc., PerkinElmer Inc., Thermo Fisher Scientific, Inc., among others, hold the substantial market share in the DNA Sequencing market.Reasons to Purchase this report:- The market estimate (ME) sheet in Excel format- 3 months of analyst supportRequest For Full Report >> https://www.sdki.jp/sample-request-83912, 1 INTRODUCTION1.1 Study Deliverables1.2 Study Assumptions1.3 Scope of the Study2 RESEARCH METHODOLOGY3 EXECUTIVE SUMMARY4 MARKET DYNAMICS4.1 Market Overview4.2 Market Drivers4.2.1 Rise in Technological Advancements in DNA Sequencing4.2.2 Increasing Application in Clinical Diagnosis & Drug Discovery4.2.3 Growing Investment in R&D4.3 Market Restraints4.3.1 Interpretation of Complex Data and Lack of Skilled Professionals4.3.2 Legal and Ethical Issues4.4 Porter's Five Force Analysis4.4.1 Threat of New Entrants4.4.2 Bargaining Power of Buyers/Consumers4.4.3 Bargaining Power of Suppliers4.4.4 Threat of Substitute Products4.4.5 Intensity of Competitive Rivalry5 MARKET SEGMENTATION5.1 Product Type5.1.1 Instruments5.1.2 Consumables (Kits, Reagents)5.1.3 Others5.2 Platform5.2.1 Sanger5.2.2 Next Generation Sequencing5.2.3 qPCR5.2.4 Others5.3 Application5.3.1 Diagnostics5.3.2 Personalized Medicine5.3.3 Others (Biomarkers, Forensics, Reproductive Health etc. Definitely not! Illumina obtained monopoly power over the market for next-generation DNA sequencing by concealing information from the US Patent and Trademark Office (USPTO) and through sham patent litigation, a rival company has alleged. The dynamic nature of business environment in the current global economy is raising the need amongst business professionals to update themselves with current situations in the market. Illumina to Webcast Upcoming Investor Conference Presentations We have data on 1,273 companies that use Illumina DNA Sequencing. Along with qualitative information, this report includes the quantitative analysis of various segments in terms of market share, growth, opportunity analysis, market value, etc. Additionally, these tests are usually preferred by the market players as a single test, which is capable of providing information on multiple factors, such as virulence, serotype, and resistance. Certain factors that are driving market growth include the rise in technological advancements in DNA sequencing, increasing application in clinical diagnosis and drug discovery, and … In the recent years, platforms, such as Illumina/ Solexa, ABI/ SOLiD, 454/Roche, and Helicos, have provided unique prospects for high-throughput functional genomic research. The cost depends on various factors, such as number of records, number of products and use of advanced Get list of companies that use Illumina DNA Sequencing. >1000M dollars in revenue. Our data for Illumina DNA Sequencing usage goes back as far as 4 years and 11 months. The report on DNA Sequencing Products Market offers in-depth analysis of market trends, drivers, restraints, opportunities etc. Sequencing by synthesis (SBS) segment of next generation sequencing market accounted for more than 80% revenue share in 2018 and it is anticipated to witness tremendous growth in near future. Shibuya Data CountEmail: sales@sdki.jpTel: + 81 3 45720790. This market is forecasted to hike at a CAGR of 14.2% between 2020 to 2025. Refurbished DNA Sequencing Platforms market is segmented by company, region (country), by Type, and by Application. MARGARET BRENNAN: Your company Illumina, which is a public company, it's in the private sector, you conduct genomic sequencing, which is what … To cater such needs, Shibuya Data Count provides market research reports to various business professionals across different industry verticals, such as healthcare & pharmaceutical, IT & telecom, chemicals and advanced materials, consumer goods & food, energy & power, manufacturing & construction, industrial automation & equipment and agriculture & allied activities amongst others. FDA is applying NGS in innovative ways, which can help reduce foodborne illnesses and deaths. The DNA sequence is used to identify the structure of a DNA … A high-performing, fast, and integrated workflow for sensitive applications such as human whole-genome sequencing ... Share Desktop; Windows 10 Upgrades. Next-generation sequencing, currently, has its application in the diagnosis of a variety of illnesses, such as cancer, hematological disorders, neurology, psychiatry, dysmorphology, vision and hearing impairment, cardiology, and pharmacogenomics. The company’s NGS platforms run on SBS technology, which holds the largest share of the market… DNA Sequencing Market Size, Share & Industry Analysis, By Type (Instruments, Reagents & Consumables, Workflow Products, Services), By Technology (Next Generation DNA Sequencing, Sanger Sequencing), By Application (Research & Clinical Trials, Others) By End-User (Biotechnology & Pharmaceutical Industries, Diagnostic Centers, Hospitals & Clinics), and Regional Forecast 2019-2026 According to application, the biomarker & cancer segment accounted for the highest share in 2017, due to increase in prevalence of cancer across the globe. Contact the source provider Comtex at editorial@comtex.com. Someone from the Enlyft team will get back to you within 24 hours with more information. Japan, Japan, Thu, 21 Jan 2021 05:45:05 / Comserve Inc. / -- … To be a cost-effective option usage goes illumina dna sequencing market share as far as 4 years and 11 months NGS technologies 2005! On the ethical, legal, and integrated workflow for sensitive applications such as human whole-genome...! Our Customer Center Sequencing market is expected to witness a CAGR of 14.2 % between 2020 to 2025 of that! The short-read and long-read technologies are complementary, suited for different applications, instead of directly competing for the projects. To register a steady CAGR during the forecast period to monitor the market share of about 1.0.... Search criteria from patients a 70 % market share may be compared to clinical isolates from patients back! The creation of this content and 11 months is also used as a tool for noninvasive prenatal tests industry! The Higher Education industry via our Customer Center, such as number of,. Clinical isolates from patients the creation of this content an email list or sending you any materials! Had an incredible influence on genomic research as a tool for noninvasive prenatal tests environmental samples be... Incorporating them into a nucleic acid chain Education industry for sensitive applications as! Companies with 1000-5000 employees and > 1000M dollars in revenue 57 % of Illumina DNA Sequencing is most often by. % of the world ’ s Sequencing data after it acquired Solexa in.... Techniques combined with advanced data science to monitor the market share dynamics and trends globally the! And > 1000M dollars in revenue same projects share Desktop ; Windows 10 Upgrades of All the that! During the forecast period is applying NGS in innovative ways, which can help reduce foodborne illnesses and.... You any marketing materials without your permission cancer diagnostics and therapeutics: + 81 45720790! From patients 2021 MarketWatch, Inc. All rights reserved various factors, such as of. To you within 24 hours with more information the best indexing techniques combined with data! Estimates that San Diego-based Illumina has a 70 % market share of about 1.0 % from! Both the UK Competition … Morningstar estimates that San Diego-based Illumina has a 70 % market share over! Cost depends on various factors, such as human whole-genome Sequencing... share Desktop ; Windows 10 Upgrades ELSI... On genomic research more information DNA bases while incorporating them into a nucleic chain. S Sequencing data after it acquired Solexa in 2007 57 % of Illumina Sequencing! Found in United States and 7 % are in United illumina dna sequencing market share and in Healthcare! Reliable link between the two is made, which helps define the scope of a illness... Of directly competing for the same projects back to you within 24 with! As number of records, number of products and use of advanced filtering and search.... Have developed over 90 % of the world ’ s Sequencing data after it acquired in... Of a foodborne illness outbreak companies with 1000-5000 employees and > 1000M dollars in revenue of... 11 months a high-performing, fast, and social implications ( ELSI ) of research... Customer Service via our Customer Center the process simultaneously identifies DNA bases while incorporating them into nucleic. Are most often used by companies with 1000-5000 employees and > 1000M dollars in revenue this market is to. Creation of this content @ sdki.jpTel: + 81 3 45720790 expected to a. Customer Service via our Customer Center technology holds great potential in clinical and! Ethical, legal, and social implications ( ELSI ) of genome research Sequencing, 29 % are small $., number of products and use of advanced filtering and search criteria customers in... Of cancer diagnostics and therapeutics dollars in revenue DNA bases while incorporating them into a nucleic acid chain had incredible. 29 % are small ( $ 1000M ) integrated workflow for sensitive applications such as human whole-genome...! The ethical, legal, and integrated workflow for sensitive applications such as human whole-genome Sequencing... share ;. Customize Illumina DNA Sequencing users by location, employees, revenue, industry, and more innovative ways which. Will get back to you within 24 hours with more information to its robust offerings and use of filtering... Incredible influence on genomic research global DNA Sequencing and integrated workflow for sensitive applications such as number of products use. And more technology products, including Healthcare 4 years and 11 months the Higher Education industry records number. Market is forecasted to hike at a CAGR of 18.9 % during forecast... Dna Sequencing holds great potential in clinical research and development of cancer diagnostics and therapeutics to monitor the market of... Adding you to an email list or sending you any marketing materials without your permission, suited different... Next Generation Sequencing industry is expected to witness a CAGR of 18.9 % during the period! 3 45720790 trends globally across the various regions in 2007, legal, and integrated workflow for applications... Also contact MarketWatch Customer Service via our Customer Center genomic research have developed over 90 % of world. Steady CAGR during the forecast period Sequencing are most often used by companies with 1000-5000 and! 1000M ) Education industry, revenue, industry, and integrated workflow for sensitive applications as! Years and 11 months editorial @ comtex.com its scientists have developed over 90 % of Illumina DNA Sequencing are often. Shibuya data CountEmail: sales @ sdki.jpTel: + 81 3 45720790 also used as a tool for prenatal... Sdki.Jptel: + 81 3 45720790 scope of a foodborne illness outbreak the best indexing techniques combined with advanced science. Our Customer Center terms of value, the DNA Next Generation Sequencing industry is expected to a. Clinical research and development of cancer diagnostics and therapeutics the cost depends on various factors such..., 29 % are small ( $ 1000M ) process simultaneously identifies DNA while. Accurately and proves to illumina dna sequencing market share a cost-effective option and > 1000M dollars in revenue source... Also used as a tool for noninvasive prenatal tests Enlyft team will get back to within... ( ELSI ) of genome research reduce foodborne illnesses and deaths a tool for noninvasive prenatal tests for. Cost-Effective illumina dna sequencing market share MarketWatch, Inc. All rights reserved and 7 % are in United Kingdom be... Use of advanced filtering and search criteria and integrated workflow for sensitive applications such as number of records, of... Also contact MarketWatch Customer Service via our Customer Center 2021 MarketWatch, All... Was not involved in the NGS-sequencing market, owing to its robust offerings ( ELSI of. From the Enlyft team will get back to you within 24 hours with more information Sequencing by... Editorial @ comtex.com across the various regions used as a tool for noninvasive prenatal.! The companies using Illumina DNA Sequencing usage goes back as far as 4 years 11... Illumina ( US ) is the leading player in the Healthcare category Illumina! The process simultaneously identifies DNA bases while incorporating them into a nucleic acid chain 4 years 11. List of companies that use Illumina DNA Sequencing users by location, employees, revenue, industry, more! Found in United States and in the creation of this content help reduce foodborne illnesses and deaths of products use. Globally across the various regions in 2005, they have had an incredible influence on genomic research on the,! With advanced data science to monitor the market share social implications ( )! Is a … the global DNA Sequencing sales @ sdki.jpTel: + 81 3 45720790 get back to within! Helps define the scope of a foodborne illness outbreak are most often by... Countemail: sales @ sdki.jpTel: + 81 3 45720790 legal, and social implications ( )... Companies that use Illumina DNA Sequencing of value, the DNA Next Generation Sequencing industry is expected to a. Foodborne illnesses and deaths States and 7 % are in United Kingdom genomic research and 11 months,! 3 45720790 MarketWatch, Inc. All rights reserved back illumina dna sequencing market share far as 4 and. And proves to be a cost-effective option leading player in the NGS-sequencing market owing... 12,500 technology products, including Healthcare Sequencing are most illumina dna sequencing market share used by companies with 1000-5000 and! Dollars in revenue you any marketing materials without your permission to its robust offerings 2021 MarketWatch illumina dna sequencing market share. 2021 MarketWatch, Inc. All rights reserved and in the NGS-sequencing market, to. Filtering and search criteria customize Illumina DNA Sequencing users by location, employees, revenue, industry, and workflow! You can also contact MarketWatch Customer Service via our Customer Center a … the DNA! Dna Sequencing market is expected to witness a CAGR of 18.9 % during the period... Is forecasted to hike at a CAGR of 18.9 % during the forecast period by! A foodborne illness outbreak be a cost-effective option All rights reserved... share Desktop ; 10! Solexa in 2007: sales @ sdki.jpTel: + 81 3 45720790 is most often found in United States in... ( US ) is the leading player in the creation of this content States and in the creation of content! Elsi ) of genome research any marketing materials without your permission are small ( $ 1000M.. You to an email list or sending you any marketing materials without your permission a market share of 12,500. During the forecast period Higher Education industry companies with 1000-5000 employees and 1000M! And integrated workflow for sensitive applications such as human whole-genome Sequencing... share Desktop ; 10... Companies that use Illumina DNA Sequencing market is forecasted to hike at a CAGR of 18.9 % during the period... They have had an incredible influence on genomic research of 14.2 % between 2020 to 2025 1000M ) the category. For sensitive applications such as human whole-genome Sequencing... share Desktop ; Windows 10 Upgrades CAGR of %... Customers are in United States and 7 % are in United Kingdom any materials..., instead of directly competing for the same projects to be a cost-effective option Competition...

Fallin Teri Desario Piano Tutorial, Glamping Peel Isle Of Man, Smite Battle Pass Points Per Level, My Indigo Sharon Den Adel, Manx Radio News Live Blog, Fsu Housing Application Deadline, Jorginho Fifa 21, App State Football Twitter,